Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mast Cell Disorder”

184 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 184 results

Not applicableStudy completedNCT02161523
What this trial is testing

The Impact of Lung Cancer-derived Fibroblasts on Mast Cells Activation

Who this might be right for
Lung Cancer
Meir Medical Center 20
Not applicableStudy completedNCT02441166
What this trial is testing

Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis

Who this might be right for
Systemic Mastocytosis
University Hospital, Toulouse 250
Early research (Phase 1)Looking for participantsNCT07181369
What this trial is testing

GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria

Who this might be right for
Healthy SubjectsCold UrticariaSymptomatic Dermographism+1 more
Granular Therapeutics Limited 72
Large-scale testing (Phase 3)UnknownNCT05084872
What this trial is testing

Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients

Who this might be right for
Mastocytosis
University Hospital, Toulouse 30
Large-scale testing (Phase 3)Study completedNCT03401060
What this trial is testing

Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis

Who this might be right for
OsteoporosisSystemic Mastocytosis
Assistance Publique - Hôpitaux de Paris 24
Early research (Phase 1)Study completedNCT02808793
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002

Who this might be right for
Indolent Systemic Mastocytosis
Allakos Inc. 25
Very early researchActive Not RecruitingNCT05206227
What this trial is testing

Histamine as a Molecular Transducer of Adaptation to Exercise

Who this might be right for
Postexercise Hypotension
University of Oregon 80
Post-approval studies (Phase 4)UnknownNCT06307288
What this trial is testing

Efficacy and Safety of Tranilast Combined With Minocycline in the Treatment of Rosacea

Who this might be right for
Rosacea
Second Affiliated Hospital of Xi'an Jiaotong University 45
Not applicableNot Yet RecruitingNCT05292768
What this trial is testing

Are Mast Cells Involved in Autoinflammatory Diseases

Who this might be right for
Autoinflammatory DiseaseFMFTRAPS+3 more
Assistance Publique - Hôpitaux de Paris 590
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Post-approval studies (Phase 4)Study completedNCT01144832
What this trial is testing

Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists

Who this might be right for
Irritable Bowel Syndrome
KU Leuven 55
Not applicableStudy completedNCT00887939
What this trial is testing

Pathogenesis of Physical Induced Urticarial Syndromes

Who this might be right for
Hypersensitivity, ImmediateAutoinflammatory SyndromesPhysical Urticaria+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 173
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Early research (Phase 1)Looking for participantsNCT05362773
What this trial is testing

MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Leukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more
MacroGenics 130
Early research (Phase 1)Ended earlyNCT05609942
What this trial is testing

Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies

Who this might be right for
Advanced Systemic Mastocytosis
Blueprint Medicines Corporation 9
Not applicableStudy completedNCT02503800
What this trial is testing

The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy

Who this might be right for
Hypersensitivity, ImmediateInsect Bites and StingsMastocytosis
Meir Medical Center 159
Not applicableStudy completedNCT03406325
What this trial is testing

Mast Cell Activation Test in Allergic Disease

Who this might be right for
AsthmaMastocytosisMast Cell Activation Syndrome+4 more
Hong Kong Sanatorium & Hospital 19
Not applicableStudy completedNCT04695431
What this trial is testing

Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM

Who this might be right for
Advanced Systemic MastocytosisAggressive Systemic MastocytosisSystemic Mastocytosis With an Associated Hematological Neoplasm+1 more
Blueprint Medicines Corporation 317
Very early researchStudy completedNCT00424242
What this trial is testing

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Northwestern University 15
Large-scale testing (Phase 3)Study completedNCT01481909
What this trial is testing

Study on Mastocytosis for Rupatadine Treatment

Who this might be right for
Mastocytosis
Marcus Maurer 30
Load More Results